GlaxoSmithKline plc's (GSK) "Buy" Rating Reiterated at Beaufort Securities

GlaxoSmithKline plc's (GSK) "Buy" Rating Reiterated at Beaufort Securities


's stock had its "buy" rating reaffirmed by analysts at Beaufort Securities in a research note issued on Thursday, StockTargetPrices.com reports. They currently have a GBX 1,750 target price on the stock.



from Biotech News